Razelle Kurzrock, Founding Director of Michels Rare Cancers Research Laboratories at the Medical College of Wisconsin and Co-Founder and Board Member at CureMatch, shared a post on X:
“Honored to chair Precision Oncology and Diagnostics meeting: Karen Milesky, who lost her husband for lack of DYPD testing (5FU toxicity), talks with Turna Ray regarding advocacy/how to change practice. Applicable to NGS too; patients not tested miss out on critical therapeutics.”
Razelle Kurzrock/X
More posts featuring Razelle Kurzrock.